413
Views
1
CrossRef citations to date
0
Altmetric
Review

The role of alpha7 nicotinic acetylcholine receptors in inflammatory bowel disease: involvement of different cellular pathways

, &
Pages 161-176 | Received 24 Jun 2017, Accepted 18 Dec 2017, Published online: 03 Jan 2018

References

  • Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011 Nov 3;365(18):1713–1725. PubMed PMID: 22047562; eng.
  • Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet (London, England). 2012 Nov 3;380(9853):1590–1605. PubMed PMID: 22914295; eng.
  • Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009 Jun;265(6):663–679. PubMed PMID: 19493060; PubMed Central PMCID: PMCPmc4540232. eng.
  • Sun P, Zhou K, Wang S, et al. Involvement of MAPK/NF-kappaB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One. 2013;8(8):e69424. PubMed PMID: 23936328; PubMed Central PMCID: PMCPmc3732220. eng.
  • Neurath MF. Cytokines in inflammatory bowel disease [Review]. Nat Rev Immunol. 201405//print;14(5):329–342.
  • Wei J, Feng J. Signaling pathways associated with inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov. 2010 Jun;4(2):105–117. PubMed PMID: 20001899;.
  • Lindgren S, Lilja B, Rosen I, et al. Disturbed autonomic nerve function in patients with Crohn’s disease. Scand J Gastroenterol. 1991 Apr;26(4):361–366. PubMed PMID: 2034989; eng.
  • Maunder RG, Nolan RP, Hunter JJ, et al. Relationship between social support and autonomic function during a stress protocol in ulcerative colitis patients in remission. Inflamm Bowel Dis. 2012 Apr;18(4):737–742. PubMed PMID: 21688349; eng.
  • Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008 Jun;118(6):2209–2218. PubMed PMID: 18451995; PubMed Central PMCID: PMC2350428.
  • Ghia JE, Blennerhassett P, Deng Y, et al. R model of depression. Gastroenterology. 2009 Jun;136(7):2280-8.e1-4. PubMed PMID: 19272381; eng.
  • Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005 Aug;4(8):673–684. PubMed PMID: 16056392; eng.
  • Nugent FW, Roy MA. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989 Mar;84(3):249–254. PubMed PMID: 2919581; eng.
  • Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology. 2006 Oct;131(4):1122–1130. PubMed PMID: 17030182.
  • Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2007 Sep;293(3):G560–G567. PubMed PMID: 17585014; eng.
  • Ghia JE, Blennerhassett P, El-Sharkawy RT, et al. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G711–G718. PubMed PMID: 17673544; eng.
  • Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004 Nov;10(11):1216–1221. PubMed PMID: 15502843.
  • de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005 Aug;6(8):844–851. PubMed PMID: 16025117; eng.
  • Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003 Jan 23;421(6921):384–388. PubMed PMID: 12508119; eng.
  • Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000 May 25;405(6785):458–462. PubMed PMID: 10839541; eng.
  • Ji H, Rabbi MF, Labis B, et al. Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 2014 Mar;7(2):335–347. PubMed PMID: 23881354; PubMed Central PMCID: PMC3859808.
  • Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. PubMed PMID: 2294996; eng.
  • Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol. 2005 Jun 15;174(12):7487–7491. PubMed PMID: 15944246; eng.
  • Gotti C, Clementi F, Fornari A, et al. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol. 2009 Oct 1;78(7):703–711. PubMed PMID: 19481063; eng.
  • Millar NS, Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology. 2009;56(1):237–246.
  • Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004 Dec;74(6):363–396. PubMed PMID: 15649582; eng.
  • Kawashima K, Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci. 2008 Feb;106(2):167–173. PubMed PMID: 18285657; eng.
  • Yoshikawa H, Kurokawa M, Ozaki N, et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol. 2006 Oct;146(1):116–123. PubMed PMID: 16968406; PubMed Central PMCID: PMCPmc1809735. eng.
  • Yue Y, Liu R, Cheng W, et al. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-kappaB signaling pathway through the alpha7 nicotinic acetylcholine receptor. Int Immunopharmacol. 2015 Dec;29(2):504–512. PubMed PMID: 26490221; eng.
  • Kawashima K, Yoshikawa K, Fujii YX, et al. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 2007 May 30;80(24–25):2314–2319. PubMed PMID: 17383684; eng.
  • Koval LM, Yu Lykhmus O, Omelchenko DM, et al. The role of alpha7 nicotinic acetylcholine receptors in B lymphocyte activation. Ukr Biokhim Zh (1999). 2009 Jul-Aug;81(4):5–11. PubMed PMID: 20387628; eng.
  • Razani-Boroujerdi S, Boyd RT, Davila-Garcia MI, et al. T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J Immunol. 2007 Sep 1;179(5):2889–2898. PubMed PMID: 17709503; eng.
  • Hayashi S, Hamada T, Zaidi SF, et al. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice. Am J Physiol Gastrointest Liver Physiol. 2014 Nov 15;307(10):G968–G978. PubMed PMID: 25258409; eng.
  • Su X, Matthay MA, Malik AB. Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol. 2010 Jan 1;184(1):401–410. PubMed PMID: 19949071; PubMed Central PMCID: PMCPmc2877486. eng.
  • Chatterjee PK, Al-Abed Y, Sherry B, et al. Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Physiol. 2009;297(5):C1294–C306.
  • Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem. 2004 Apr;89(2):337–343. PubMed PMID: 15056277; eng.
  • Yamamoto T, Kodama T, Lee J, et al. Anti-allergic role of cholinergic neuronal pathway via alpha7 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model. PLoS One. 2014;9(1):e85888. PubMed PMID: 24454942; PubMed Central PMCID: PMCPmc3894205. eng.
  • Dang X, Eliceiri BP, Baird A, et al. CHRFAM7A: a human-specific alpha7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS. Faseb J. 2015 Jun;29(6):2292–2302. PubMed PMID: 25681457; eng.
  • Bertrand D, Lee CH, Flood D, et al. Therapeutic potential of alpha7 nicotinic acetylcholine receptors. Pharmacol Rev. 2015 Oct;67(4):1025–1073. PubMed PMID: 26419447;.
  • Ghia JE, Park AJ, Blennerhassett P, et al. Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis. Inflamm Bowel Dis. 2011 Jul;17(7):1474–1489. PubMed PMID: 21246669; eng.
  • Snoek SA, Verstege MI, van der Zanden EP, et al. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol. 2010 May;160(2):322–333. PubMed PMID: 20423343; PubMed Central PMCID: PMCPmc2874854. eng.
  • Monteleone I, Pallone F, Monteleone G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med. 2011;9:122. PubMed PMID: 22082127; PubMed Central PMCID: PMCPmc3239315. eng.
  • Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol. 2008 Jul 21;14(27):4280–4288. PubMed PMID: 18666314; PubMed Central PMCID: PMCPmc2731177. eng.
  • Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res. 2005 Jan;15(1):24–27. PubMed PMID: 15686622; eng.
  • Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008 Feb;118(2):560–570. PubMed PMID: 18219394; PubMed Central PMCID: PMCPmc2213370. eng.
  • Naito Y, Takagi T, Uchiyama K, et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med. 2004 Aug;14(2):191–196. PubMed PMID: 15254764; eng.
  • Galitovskiy V, Qian J, Chernyavsky AI, et al. Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol. 2011 Sep 1;187(5):2677–2687. PubMed PMID: 21784975; PubMed Central PMCID: PMCPmc4260719. eng.
  • Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (New York, NY). 2011 Oct 7;334(6052):98–101. PubMed PMID: 21921156; PubMed Central PMCID: PMCPmc4548937. Eng.
  • Ghia JE, Galeazzi F, Ford DC, et al. Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus. Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G770–7. PubMed PMID: 18202111; eng.
  • Sainathan SK, Hanna EM, Gong Q, et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis. 2008 Jan;14(1):88–99. PubMed PMID: 17932977; PubMed Central PMCID: PMCPmc4565141. eng.
  • Watanabe N, Ikuta K, Okazaki K, et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci. 2003 Feb;48(2):408–414. PubMed PMID: 12643623; eng.
  • Hume DA. The many alternative faces of macrophage activation. Front Immunol. 2015;6:370. PubMed PMID: 26257737; PubMed Central PMCID: PMCPmc4510422. eng.
  • Tracey KJ. The inflammatory reflex. Nature. 2002 Dec 19–26;420(6917):853–859. PubMed PMID: 12490958; eng.
  • Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med. 2008 Sep-Oct;14(9–10):567–574. PubMed PMID: 18584048; PubMed Central PMCID: PMCPmc2435495. eng.
  • te Velde AA, van Kooyk Y, Braat H, et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn’s disease. Eur J Immunol. 2003 Jan;33(1):143–151. PubMed PMID: 12594843; eng.
  • Berndt BE, Zhang M, Chen GH, et al. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol. 2007 Nov 1;179(9):6255–6262. PubMed PMID: 17947701; eng.
  • Munyaka P, Rabbi MF, Pavlov VA, et al. Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitis. PLoS One. 2014;9(10):e109272. PubMed PMID: 25295619; PubMed Central PMCID: PMC4190311.
  • Karimi K, Bienenstock J, Wang L, et al. The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun. 2010 Feb;24(2):316–323. PubMed PMID: 19887104; eng.
  • Nouri-Shirazi M, Tinajero R, Guinet E. Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs). Immunology Letters. 2007 Apr 15;109(2):155–164. PubMed PMID: 17368810; eng.
  • Salaga M, Blomster LV, Piechota-Polańczyk A, et al. Encenicline, an α7 nicotinic acetylcholine receptor partial agonist, reduces immune cell infiltration in the colon and improves experimental colitis in mice. J Pharmacol Exp Ther. 2016 January 1;356(1):157–169.
  • Martelli D, McKinley MJ, McAllen RM. The cholinergic anti-inflammatory pathway: a critical review. Auton Neurosci. 2014 May;182:65–69. PubMed PMID: 24411268; eng.
  • Sykes AP, Brampton C, Klee S, et al. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res. 2000 Jul;49(7):311–319. PubMed PMID: 10959551; eng.
  • Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, et al. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med. 2009 Jul-Aug;15(7–8):195–202. PubMed PMID: 19593403; PubMed Central PMCID: PMCPmc2707516. eng.
  • De Simone R, Ajmone-Cat MA, Carnevale D, et al. Activation of α7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E(2)in rat microglial cultures. J Neuroinflammation. 2005 01/25. 12/14/received, 01/25/accepted;2:4. PubMed PMID: PMC548670;.
  • Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009 Nov;9(11):798–809. PubMed PMID: 19851315; eng.
  • Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009 Feb 3;15(2):103–113. PubMed PMID: 19185845; PubMed Central PMCID: PMCPmc2667107. eng.
  • Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009 Feb 3;15(2):91–102. PubMed PMID: 19185844; eng
  • Yang YH, Li DL, Bi XY, et al. Acetylcholine inhibits LPS-induced MMP-9 production and cell migration via the α7 nAChR-JAK2/STAT3 pathway in RAW264.7 cells. Cell Physiol Biochem. 2015;36(5):2025–2038.
  • Shaw S, Bencherif M, Marrero MB. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem. 2002 Nov 22;277(47):44920–44924. PubMed PMID: 12244045; eng.
  • Yang J, Liao X, Agarwal MK, et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007 Jun 1;21(11):1396–1408. PubMed PMID: 17510282; PubMed Central PMCID: PMCPmc1877751. eng.
  • Ulloa L. The cholinergic anti-inflammatory pathway meets microRNA [Research Highlight]. 11//print Cell Res. 2013;2311:1249–1250. 10.1038/cr.2013.128
  • Zhang S, Day IN, Ye S. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomics. 2001 Apr 27;5(4):187–192. PubMed PMID: 11328964; eng.
  • Bai A, Guo Y, Lu N. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol. 2007 Nov;66(5):538–545. PubMed PMID: 17953529; eng.
  • Orr-Urtreger A, Kedmi M, Rosner S, et al. Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport. 2005 Jul 13;16(10):1123–1127. PubMed PMID: 15973160; eng.
  • Tsubouchi R, Hayashi S, Aoi Y, et al. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats. Digestion. 2006;74(2):91–100. PubMed PMID: 17143008; eng.
  • Ye YN, Liu ES, Shin VY, et al. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. Toxicology. 2004 Oct 15;203(1–3):179–188. PubMed PMID: 15363593; eng.
  • Cuzzocrea S, Ianaro A, Wayman NS, et al. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br J Pharmacol. 2003 Feb;138(4):678–688. PubMed PMID: 12598422; PubMed Central PMCID: PMCPmc1573694. eng.
  • Hendel J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol. 1997 Jul;92(7):1170–1173. PubMed PMID: 9219792; eng.
  • Motley RJ, Rhodes J, Williams G, et al. Smoking, eicosanoids and ulcerative colitis. J Pharm Pharmacol. 1990 Apr;42(4):288–289. PubMed PMID: 1974301; eng.
  • Guo X, Liu ES, Ko JK, et al. Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats. Eur J Pharmacol. 2001 Jan 5;411(1–2):193–203. PubMed PMID: 11137876; eng.
  • Liu ES, Ye YN, Shin VY, et al. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis. 2003 Aug;24(8):1407–1413. PubMed PMID: 12807736; eng.
  • Liu ES-L, Ye Y-N, Shin VY, et al. Interaction of cigarette smoking with cyclooxygenase-2 on ulcerative colitis-associated neoplasia in mice. Cancer Invest. 2009;25(8):750–757.
  • Ye YN, Liu ES, Shin VY, et al. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther. 2004 Jan;308(1):66–72. PubMed PMID: 14569062; eng.
  • Pai R, Soreghan B, Szabo IL, et al. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002 Mar;8(3):289–293. PubMed PMID: 11875501; eng.
  • Eliakim R, Karmeli F, Rachmilewitz D, et al. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur J Gastroenterol Hepatol. 1998 Dec;10(12):1007–1020. PubMed PMID: 9895047; eng.
  • Qiu BS, Deng YK, Galeazzi F, et al. Neural involvement in the bivalent action of nicotine on experimental colitis in rats. Gastroenterology. 1997;112:A1065.
  • Hawkins PT, Anderson KE, Davidson K, et al. Signalling through class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006 Nov;34(Pt 5):647–662. PubMed PMID: 17052169; eng.
  • Rehani K, Scott DA, Renaud D, et al. Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. Biochim Biophys Acta. 2008 Mar;1783(3):375–382. PubMed PMID: 18178163; eng.
  • Cucina A, Dinicola S, Coluccia P, et al. Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways. J Surg Res. 2012 Nov;178(1):233–241. PubMed PMID: 22520577; eng.
  • Ojaniemi M, Glumoff V, Harju K, et al. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol. 2003;33(3):597–605.
  • Coskun M, Olsen J, Seidelin JB, et al. MAP kinases in inflammatory bowel disease. Clin Chim Acta. 2011 Mar 18;412(7–8):513–520. PubMed PMID: 21185271; eng.
  • Tan J, Town T, Saxe M, et al. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol. 1999 Dec 15;163(12):6614–6621. PubMed PMID: 10586056; eng.
  • The F, Cailotto C, van der Vliet J, et al. Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus. Br J Pharmacol. 2011 Jul;163(5):1007–1016. PubMed PMID: 21371006; PubMed Central PMCID: PMCPmc3130947. eng.
  • Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci. 2008 Mar;29(3):151–158. PubMed PMID: 18262664; eng.
  • Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem. 2011 Mar;67(1):129–139. PubMed PMID: 20981514; eng.
  • Sun Y, Li Q, Gui H, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines [original article]. Cell Res . 2013;23(11):1270–1283. 11//print.
  • Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004 Nov;10(6):848–859. PubMed PMID: 15626903; eng.
  • Koopman FA, Chavan SS, Miljko S, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci. 2016 July 19;113(29):8284–8289.
  • Stakenborg N, Wolthuis AM, Gomez-Pinilla PJ, et al. Abdominal vagus nerve stimulation as a new therapeutic approach to prevent postoperative ileus. Neurogastroenterol Motil. 2017 Sep;29(9). PubMed PMID: 28429863; eng.
  • Clarencon D, Pellissier S, Sinniger V, et al. Long term effects of low frequency (10 hz) vagus nerve stimulation on EEG and heart rate variability in Crohn’s disease: a case report. Brain Stimul. 2014 Nov-Dec;7(6):914–916. PubMed PMID: 25263316; eng.
  • Bonaz B, Sinniger V, Hoffmann D, et al. Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016 Jun;28(6):948–953. PubMed PMID: 26920654; eng.
  • Bonaz B, Sinniger V, Pellissier S. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease. J Intern Med. 2017 Jul;282(1):46–63. PubMed PMID: 28421634; eng.
  • Zhao HY, Yang GT, Sun NN, et al. Efficacy and safety of stellate ganglion block in chronic ulcerative colitis. World J Gastroenterol. 2017 Jan 21;23(3):533–539. PubMed PMID: 28210090; PubMed Central PMCID: PMCPMC5291859. eng.
  • Olincy A, Blakeley-Smith A, Johnson L, et al. Brief report: initial trial of alpha7-nicotinic receptor stimulation in two adult patients with autism spectrum disorder. J Autism Dev Disord. 2016 Dec;46(12):3812–3817. PubMed PMID: 27565651; eng.
  • Becker B, Klein EM, Striepens N, et al. Nicotinic acetylcholine receptors contribute to learning-induced metaplasticity in the hippocampus. J Cogn Neurosci. 2013 Jul;25(7):986–997. PubMed PMID: 23469888; eng.
  • Florian H, Meier A, Gauthier S, et al. Efficacy and safety of ABT-126 in subjects with mild-to-moderate Alzheimer’s disease on stable doses of acetylcholinesterase inhibitors: a randomized, double-blind, placebo-controlled study. J Alzheimers Dis. 2016;51(4):1237–1247. PubMed PMID: 26967214; eng.
  • Freedman R, Olincy A, Buchanan RW, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry. 2008 Aug;165(8):1040–1047. PubMed PMID: 18381905; PubMed Central PMCID: PMCPMC3746983. eng.
  • Kox M, Pompe JC, Gordinou de Gouberville MC, et al. Effects of the alpha7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans. Shock (Augusta, Ga). 2011 Jul;36(1):5–11. PubMed PMID: 21368716; eng.
  • Briggs CA, Anderson DJ, Brioni JD, et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav. 1997 May-Jun;57(1–2):231–241. PubMed PMID: 9164577; eng.
  • Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia [cited 2017 Dec 5]. Available from: https://ClinicalTrials.gov/show/NCT00669903;
  • Sydserff S, Sutton EJ, Song D, et al. Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. Biochem Pharmacol. 2009 Oct 1;78(7):880–888. PubMed PMID: 19615981; eng
  • Trenkwalder C, Berg D, Rascol O, et al. A placebo-controlled trial of AQW051 in patients with moderate to severe levodopa-induced dyskinesia. Mov Disord. 2016 Jul;31(7):1049–1054. PubMed PMID: 26990766; eng.
  • Lewis AS, van Schalkwyk GI, Bloch MH. Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: a translational meta-analysis of rodent and human studies. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:45–53.
  • Nikiforuk A, Kos T, Potasiewicz A, et al. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. Eur Neuropsychopharmacol. 2015 Aug;25(8):1300–1313. PubMed PMID: 26003081; eng.
  • Williams DK, Wang J, Papke RL. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem Pharmacol. 2011 Oct 15;82(8):915–930. PubMed PMID: 21575610; PubMed Central PMCID: PMCPMC3162128. eng.
  • Rezvani AH, Kholdebarin E, Brucato FH, et al. Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):269–275. PubMed PMID: 19110025; eng.
  • Umbricht D, Keefe RS, Murray S, et al. A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2014 Jun;39(7):1568–1577. PubMed PMID: 24549101; PubMed Central PMCID: PMCPMC4023143. eng.
  • van Assche G, Vermeire S, Rutgeerts P. Medical treatment of inflammatory bowel diseases. Curr Opin Gastroenterol. 2005 Jul;21(4):443–447. PubMed PMID: 15930985; eng.
  • Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine–a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov;2(11):536–544. PubMed PMID: 16355159; eng.
  • Ingram JR, Thomas GA, Rhodes J, et al. A randomized trial of nicotine enemas for active ulcerative colitis. Clin Gastroenterol Hepatol. 2005 Nov;3(11):1107–1114. PubMed PMID: 16271342; eng.
  • Dotan I, Rachmilewitz D, Schreiber S, et al. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn’s disease. Gut. 2010 Jun;59(6):760–766. PubMed PMID: 20551461; eng.
  • Papke RL, Stokes C, Damaj MI, et al. Persistent activation of alpha7 nicotinic ACh receptors associated with stable induction of different desensitized states. Br J Pharmacol. 2017 May 6. PubMed PMID: 28477386; eng.
  • Mousavizadeh K, Rahimian R, Fakhfouri G, et al. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. Eur J Clin Invest. 2009 May;39(5):375–383. PubMed PMID: 19302562.
  • Wittebole X, Fau HS, Coyle SM, et al. Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol. 2006; 20061220 DCOM- 20070329(0009-9104 (Print)). doi: D - NLM: PMC1810444 EDAT- 2006/12/2109:00 MHDA- 2007/ 03/3009:00 CRDT- 2006/ 12/2109:00 AID - CEI3248 [pii] AID - 10.1111/j.1365-2249.2006.03248.x [doi] PST - ppublish. eng.
  • Kox M, Pompe JC, Peters E, et al. Alpha7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-alpha production and lung injury. Br J Anaesth. 2011 Oct;107(4):559–566. PubMed PMID: 21771746; eng.
  • Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016 Oct 15;594(20):5781–5790. PubMed PMID: 27059884; PubMed Central PMCID: PMCPMC5063949. eng.
  • Clancy JA, Mary DA, Witte KK, et al. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 2014 Nov-Dec;7(6):871–877. PubMed PMID: 25164906; eng.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.